Regenass Healthcare Group

Obesity Medicine in Ontario, California

Practice Details

Address
1910 S Archibald Ave Ste M2
Ontario, CA 91761
Geocoded location: 34.0390, -117.5933
Taxonomy
Obesity Medicine (Preventive Medicine)
NPPES Enumeration
Listed with NPPES since 2023
Registered Contact
DOMINADOR MANSAT, CFO
NPPES Record Updated
May 2023

About This Practice

This practice is enumerated under Obesity Medicine, a Preventive Medicine subspecialty focused specifically on the medical management of obesity — including behavioral counseling, nutrition, and pharmacotherapy such as GLP-1 receptor agonists. Obesity-medicine specialists in Ontario are among the practices most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices.

Locally, this is 1 of 2 Obesity Medicine (Preventive Medicine) practices in Ontario carrying this exact taxonomy in our directory.

What to expect at an Obesity Medicine visit

A first visit at an obesity-medicine practice generally centers on a medical work-up rather than a quick prescription. In broad terms, patients often encounter:

  • A weight and health history, BMI/body-composition review, and discussion of prior weight-loss attempts.
  • A conversation about treatment options — lifestyle changes, and where appropriate anti-obesity medications such as GLP-1 receptor agonists (semaglutide, tirzepatide).
  • Baseline labs (e.g. A1c, metabolic panel, lipids) to screen for diabetes and metabolic conditions before starting medication.
  • A cost and coverage discussion, since many commercial plans limit obesity-only GLP-1 coverage and may require prior authorization.

This is general guidance for obesity medicine practices, not a description of Regenass Healthcare Group's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 909-348-2556.

GLP-1 access in Ontario, California

Adult obesity rate
28.1%
#44 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$219/mo
Typical California telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
California Medicaid, obesity indication

About 28.1% of California adults have obesity (BMI 30+), ranking the state #44 of 50 (CDC BRFSS). Our directory currently lists 5 GLP-1-relevant clinics in Ontario. If a cash-pay route makes more sense, compounded semaglutide through California telehealth averages about $219/mo — well below brand-name Wegovy or Zepbound.

Explore more California options on the best California GLP-1 providers page, browse every Ontario listing in the Ontario clinic directory.

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to California addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured California telehealth partners:

Featured Partners · Ontario

Featured GLP-1 providers serving Ontario

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  2. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  3. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  4. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
  5. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  6. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →

See more Ontario options on the Ontario clinic directory, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Ontario obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Regenass Healthcare Group's specialty taxonomy but not the specific medications it prescribes or its current service menu. Regenass Healthcare Group is listed under Obesity Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 909-348-2556 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Regenass Healthcare Group's primary specialty on file is Obesity Medicine.
Regenass Healthcare Group is located at 1910 S Archibald Ave Ste M2, Ontario, CA 91761. The phone number listed in the registry is 909-348-2556. Its full record is public in the CMS National Provider registry under NPI 1104516350.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Regenass Healthcare Group is currently accepting new patients. Call the practice at 909-348-2556 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.